Louise Frederika Kooij, Chief Accounting Officer at NewAmsterdam Pharma Co N.V. (NAMS), sold 150,000 shares at $20.37 ($3.1M) on 2025-03-04, disclosed to the SEC on 2025-03-05.
Open-market sale of $3.1M NAMS by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NAMS | SELL | 2026-05-27 | $2.3M | — | Filing → |
| NAMS | SELL | 2026-01-29 | $2.3M | — | Filing → |
| NAMS | SELL | 2026-01-27 | $2.4M | — | Filing → |